M2 Presswire - Shareholders alert for Schering-Plough Corp.
M2 PRESSWIRE-25 June 2007-Biotech News: Shareholders alert for Schering-Plough Corp(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:25062007 Shareholders alert for Schering-Plough Corp (NYSE:SGP) Schering-Plough Corporation engages in the discovery, development, manufacture, and marketing of medical therapies and treatments worldwide.
Most Popular
10 Jobs That Pay $30 An Hour
3 Questions No Job Seeker Ever Wants To Be Asked?
5 Regular Mistakes In Public Speaking
13 Job Interview Mistakes To Avoid
Five Questions for Michael Eisner
Its Prescription Pharmaceuticals segment offers NASONEX for nasal allergy symptoms and nasal polyps; CLARINEX for allergic rhinitis; FORADIL AEROLIZER for asthma and chronic obstructive pulmonary disease; ASMANEX TWISTHALER for asthma; PROVENTIL for the …
Read the rest of this article with a Free Trial at HighBeam Research.
